X

Pharmaceutical

Astrazeneca Pharma India Ltd Q3FY25; 69% fall in Profits

AstraZeneca Pharma India Ltd is engaged in the business of manufacture, distribution and marketing of pharmaceutical products. Financial Results: Astrazeneca…

Ipca Laboratories Ltd Q3FY25; 25% rise in Profits

Ipca Laboratories is engaged in the manufacturing and marketing of pharmaceuticals. Financial Results: Ipca Laboratories Ltd reported Revenues for Q3FY25…

Alkem Laboratories Ltd Q3FY25; 6% rise in Profits

Alkem Laboratories is engaged in pharmaceutical business with global operations. The Company is engaged in the development, manufacture and sale…

Alembic Pharmaceuticals Ltd Q3FY25; 23% fall in Profits

Alembic Pharmaceuticals is in the business of development, manufacturing, and marketing of Pharmaceuticals products i.e. Formulations and Active Pharmaceutical Ingredients.…

Ajanta Pharma Ltd Q3FY25; 11% rise in Profits

Ajanta Pharma is primarily engaged in development, manufacturing and marketing of speciality pharmaceutical quality finished dosages.(Source : 202003-01 Annual Report…

Abbott India Ltd Q3FY25; 88% fall in Profits

Abbott India Ltd is one of the leading multinational pharmaceutical companies in India and sells its products through independent distributors…

ZYDUSLIFE Q3 2024-2025 Call Highlights: Profit Jump, Robust Margins & Expansion Plans!

Zydus Lifesciences Ltd., a leading Indian Pharmaceutical company, in its Q3 earnings call discussed strong performance across multiple segments, with…

DIVISLAB Q3 2024-2025 Call Highlights: Expansion Plans, Generics Growth, and API Challenges!

Divi's Laboratories Ltd., an Indian multinational pharmaceutical company that manufactures and exports API's, Intermediates and Nutraceutical ingredients, in its Q3…

Granules India Ltd Q3FY25; 6% fall in Profits

Granules India Ltd and its subsidiaries are primarily involved in the manufacturing and selling of Active Pharma Ingredients (APIs), Pharmaceutical…

SUNPHARMA Q3 2024-2025 Call Highlights: India Leads, US Slows, Specialty Expands!

Sun Pharmaceutical Industries Ltd., the fourth largest specialty generic pharmaceutical company in the world, in its Q3 earnings call discussed…